Skip to main content

Advertisement

SpringerLink
Log in

Do Recent Epidemiologic Observations Impact Who and How We Should Screen for CRC?

  • Review
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

Colorectal cancer (CRC) screening is recommended to begin at age 50 for those patients with no significant family history of CRC. However, even within this group of average-risk patients, there is data to suggest that there may be variation in CRC risk. These observations suggest that perhaps CRC screening should be tailored to target those patients at higher risk for earlier or more invasive screening as compared to those individuals at lower risk. The strategy of how to identify those higher-risk patients may not be straightforward. One method might be to use single risk factors such as smoking or elevated BMI as has been suggested in the recent American College of Gastroenterology CRC screening guidelines. Another paradigm involves the use of models which incorporate several risk factors to stratify patients by risk. This article will highlight recent large studies that examine recognized CRC risk factors as well as review recently developed CRC risk models. There will also be a discussion of the application of these factors and models in an effort to make CRC screening more efficient.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Siegel R, Desantis C, Jemal A. Colorectal cancer statistics, 2014. CA Cancer J Clin. 2014;64:104–117.

    Article  PubMed  Google Scholar 

  2. Levin B, Lieberman DA, McFarland B, et al. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. Gastroenterology. 2008;134:1570–1595.

    Article  CAS  PubMed  Google Scholar 

  3. Rex DK, Johnson DA, Anderson JC, Schoenfeld PS, Burke CA, Inadomi JM. American College of Gastroenterology guidelines for colorectal cancer screening 2009 [corrected]. Am J Gastroenterol. 2009;104:739–750.

    Article  PubMed  Google Scholar 

  4. Screening for colorectal cancer. recommendation and rationale. Ann Intern Med. 2002;137:129–131.

    Article  Google Scholar 

  5. Zauber AG, Lansdorp-Vogelaar I, Knudsen AB, Wilschut J, van Ballegooijen M, Kuntz KM. Evaluating test strategies for colorectal cancer screening: a decision analysis for the U.S. Preventive Services Task Force. Ann Intern Med. 2008;149:659–669.

    Article  PubMed Central  PubMed  Google Scholar 

  6. Ahnen DJ, Wade SW, Jones WF, et al. The increasing incidence of young-onset colorectal cancer: a call to action. Mayo Clin Proc. 2014;89:216–224.

    Article  PubMed  Google Scholar 

  7. Lieberman D. Race, gender, and colorectal cancer screening. Am J Gastroenterol. 2005;100:2756–2758.

    Article  PubMed  Google Scholar 

  8. Hoffmeister M, Schmitz S, Karmrodt E, et al. Male sex and smoking have a larger impact on the prevalence of colorectal neoplasia than family history of colorectal cancer. Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc. 2010;8:870–876.

    Google Scholar 

  9. Poynter JN, Siegmund KD, Weisenberger DJ, et al. Molecular characterization of MSI-H colorectal cancer by MLHI promoter methylation, immunohistochemistry, and mismatch repair germline mutation screening. Cancer Epidemiol Biomarkers Prev Publ Am Assoc Cancer Res (cosponsored by the American Society of Preventive Oncology). 2008;17:3208–3215.

    Article  CAS  Google Scholar 

  10. Schoenfeld P, Cash B, Flood A, et al. Colonoscopic screening of average-risk women for colorectal neoplasia. N Engl J Med. 2005;352:2061–2068.

    Article  CAS  PubMed  Google Scholar 

  11. Lieberman DA, Holub JL, Moravec MD, Eisen GM, Peters D, Morris CD. Prevalence of colon polyps detected by colonoscopy screening in asymptomatic black and white patients. J Am Med Assoc (JAMA). 2008;300:1417–1422.

    Article  CAS  Google Scholar 

  12. Nguyen SP, Bent S, Chen YH, Terdiman JP. Gender as a risk factor for advanced neoplasia and colorectal cancer: a systematic review and meta-analysis. Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc. 2009;7:676 e1-3–681 e1-3.

    Google Scholar 

  13. Ferlitsch M, Reinhart K, Pramhas S, et al. Sex-specific prevalence of adenomas, advanced adenomas, and colorectal cancer in individuals undergoing screening colonoscopy. J Am Med Assoc (JAMA). 2011;306:1352–1358.

    Article  CAS  Google Scholar 

  14. Anderson JC, Gonzalez JD, Messina CR, Pollack BJ. Factors that predict incomplete colonoscopy: thinner is not always better. Am J Gastroenterol. 2000;95:2784–2787.

    Article  CAS  PubMed  Google Scholar 

  15. Anderson JC, Messina CR, Cohn W, et al. Factors predictive of difficult colonoscopy. Gastrointest Endosc. 2001;54:558–562.

    Article  CAS  PubMed  Google Scholar 

  16. Johnson ME, Feinn R, Anderson JC. Clinical factors associated with non-polypoid colonic adenomas >/=6 mm: a prospective study in an asymptomatic population using a high-definition colonoscope. Am J Gastroenterol. 2011;106:2018–2022.

    Article  PubMed  Google Scholar 

  17. Anderson JC, Attam R, Alpern Z, et al. Prevalence of colorectal neoplasia in smokers. Am J Gastroenterol. 2003;98:2777–2783.

    Article  PubMed  Google Scholar 

  18. Anderson JC, Latreille M, Messina C, et al. Smokers as a high-risk group: data from a screening population. J Clin Gastroenterol. 2009;43:747–752.

    Article  PubMed  Google Scholar 

  19. Anderson JC, Moezardalan K, Messina CR, Latreille M, Shaw RD. Smoking and the association of advanced colorectal neoplasia in an asymptomatic average risk population: analysis of exposure and anatomical location in men and women. Dig Dis Sci. 2011;56:3616–3623.

    Article  PubMed  Google Scholar 

  20. Anderson JC, Stein B, Kahi CJ, Rajapakse R, Walker G, Alpern Z. Association of smoking and flat adenomas: results from an asymptomatic population screened with a high-definition colonoscope. Gastrointest Endosc. 2010;71:1234–1240.

    Article  PubMed Central  PubMed  Google Scholar 

  21. Anderson JC, Rangasamy P, Rustagi T, et al. Risk factors for sessile serrated adenomas. J Clin Gastroenterol. 2011;45:694–699.

    Article  PubMed  Google Scholar 

  22. Limburg PJ, Vierkant RA, Cerhan JR, et al. Cigarette smoking and colorectal cancer: long-term, subsite-specific risks in a cohort study of postmenopausal women. Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc. 2003;1:202–210.

    Google Scholar 

  23. Botteri E, Iodice S, Raimondi S, Maisonneuve P, Lowenfels AB. Cigarette smoking and adenomatous polyps: a meta-analysis. Gastroenterology. 2008;134:388–395.

    Article  PubMed  Google Scholar 

  24. Giovannucci E. An updated review of the epidemiological evidence that cigarette smoking increases risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev Publ Am Assoc Cancer Res (cosponsored by the American Society of Preventive Oncology). 2001;10:725–731.

    CAS  Google Scholar 

  25. Anderson JC, Alpern Z, Messina CR, et al. Predictors of proximal neoplasia in patients without distal adenomatous pathology. Am J Gastroenterol. 2004;99:472–477.

    Article  PubMed  Google Scholar 

  26. Botteri E, Iodice S, Bagnardi V, Raimondi S, Lowenfels AB, Maisonneuve P. Smoking and colorectal cancer: a meta-analysis. J Am Med Assoc (JAMA). 2008;300:2765–2778.

    Article  CAS  Google Scholar 

  27. Tsoi KK, Pau CY, Wu WK, Chan FK, Griffiths S, Sung JJ. Cigarette smoking and the risk of colorectal cancer: a meta-analysis of prospective cohort studies. Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc. 2009;7:682 e1-5–688 e1-5.

    Google Scholar 

  28. Liang PS, Chen TY, Giovannucci E. Cigarette smoking and colorectal cancer incidence and mortality: systematic review and meta-analysis. Int J Cancer (Journal International du Cancer). 2009;124:2406–2415.

    Article  CAS  Google Scholar 

  29. De Pergola G, Silvestris F. Obesity as a major risk factor for cancer. J Obes. 2013;2013:291546.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  30. Larsson SC, Wolk A. Obesity and colon and rectal cancer risk: a meta-analysis of prospective studies. Am J Clin Nutr. 2007;86:556–565.

    CAS  PubMed  Google Scholar 

  31. Ben Q, An W, Jiang Y, et al. Body mass index increases risk for colorectal adenomas based on meta-analysis. Gastroenterology. 2012;142:762–772.

    Article  PubMed  Google Scholar 

  32. Hong S, Cai Q, Chen D, Zhu W, Huang W, Li Z. Abdominal obesity and the risk of colorectal adenoma: a meta-analysis of observational studies. Eur J Cancer Prev Off J Eur Cancer Prev Organ. 2012;21:523–531.

    Article  Google Scholar 

  33. Ma Y, Yang Y, Wang F, et al. Obesity and risk of colorectal cancer: a systematic review of prospective studies. PLoS One. 2013;8:e53916.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  34. White UA, Tchoukalova YD. Sex dimorphism and depot differences in adipose tissue function. Biochim Biophys Acta. 2014;1842:377–392.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  35. Anderson JC, Messina CR, Dakhllalah F, et al. Body mass index: a marker for significant colorectal neoplasia in a screening population. J Clin Gastroenterol. 2007;41:285–290.

    Article  PubMed  Google Scholar 

  36. Lieberman DA, Prindiville S, Weiss DG, Willett W. Risk factors for advanced colonic neoplasia and hyperplastic polyps in asymptomatic individuals. J Am Med Assoc (JAMA). 2003;290:2959–2967.

    Article  Google Scholar 

  37. Stein B, Anderson JC, Rajapakse R, Alpern ZA, Messina CR, Walker G. Body mass index as a predictor of colorectal neoplasia in ethnically diverse screening population. Dig Dis Sci. 2010;55:2945–2952.

    Article  PubMed  Google Scholar 

  38. Jinjuvadia R, Lohia P, Jinjuvadia C, Montoya S, Liangpunsakul S. The association between metabolic syndrome and colorectal neoplasm: systemic review and meta-analysis. J Clin Gastroenterol. 2013;47:33–44.

    Article  PubMed Central  PubMed  Google Scholar 

  39. Deng L, Gui Z, Zhao L, Wang J, Shen L. Diabetes mellitus and the incidence of colorectal cancer: an updated systematic review and meta-analysis. Dig Dis Sci. 2012;57:1576–1585.

    Article  CAS  PubMed  Google Scholar 

  40. Jiang Y, Ben Q, Shen H, Lu W, Zhang Y, Zhu J. Diabetes mellitus and incidence and mortality of colorectal cancer: a systematic review and meta-analysis of cohort studies. Eur J Epidemiol. 2011;26:863–876.

    Article  PubMed  Google Scholar 

  41. Wu L, Yu C, Jiang H, et al. Diabetes mellitus and the occurrence of colorectal cancer: an updated meta-analysis of cohort studies. Diabetes Technol Ther. 2013;15:419–427.

    Article  PubMed  Google Scholar 

  42. Janghorbani M, Dehghani M, Salehi-Marzijarani M. Systematic review and meta-analysis of insulin therapy and risk of cancer. Horm Cancer. 2012;3:137–146.

    Article  CAS  PubMed  Google Scholar 

  43. Zhang ZJ, Zheng ZJ, Kan H, et al. Reduced risk of colorectal cancer with metformin therapy in patients with type 2 diabetes: a meta-analysis. Diabetes Care. 2011;34:2323–2328.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  44. Soranna D, Scotti L, Zambon A, et al. Cancer risk associated with use of metformin and sulfonylurea in type 2 diabetes: a meta-analysis. Oncologist. 2012;17:813–822.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  45. Anderson JC, Alpern Z, Sethi G, et al. Prevalence and risk of colorectal neoplasia in consumers of alcohol in a screening population. Am J Gastroenterol. 2005;100:2049–2055.

    Article  PubMed  Google Scholar 

  46. Moskal A, Norat T, Ferrari P, Riboli E. Alcohol intake and colorectal cancer risk: a dose-response meta-analysis of published cohort studies. Int J Cancer (Journal International du Cancer). 2007;120:664–671.

    Article  CAS  Google Scholar 

  47. Mizoue T, Inoue M, Wakai K, et al. Alcohol drinking and colorectal cancer in Japanese: a pooled analysis of results from five cohort studies. Am J Epidemiol. 2008;167:1397–1406.

    Article  PubMed  Google Scholar 

  48. Fedirko V, Tramacere I, Bagnardi V, et al. Alcohol drinking and colorectal cancer risk: an overall and dose-response meta-analysis of published studies. Ann Oncol Off J Eur Soc Med Oncol (ESMO). 2011;22:1958–1972.

    Article  CAS  Google Scholar 

  49. Park JY, Mitrou PN, Dahm CC, et al. Baseline alcohol consumption, type of alcoholic beverage and risk of colorectal cancer in the European Prospective Investigation into Cancer and Nutrition-Norfolk study. Cancer Epidemiol. 2009;33:347–354.

    Article  CAS  PubMed  Google Scholar 

  50. Alexander DD, Weed DL, Cushing CA, Lowe KA. Meta-analysis of prospective studies of red meat consumption and colorectal cancer. Eur J Cancer Prev Off J Eur Cancer Prev Organ. 2011;20:293–307.

    Article  CAS  Google Scholar 

  51. Xu X, Yu E, Gao X, et al. Red and processed meat intake and risk of colorectal adenomas: a meta-analysis of observational studies. Int J Cancer (Journal International du Cancer). 2013;132:437–448.

    Article  CAS  Google Scholar 

  52. Aune D, Chan DS, Vieira AR, et al. Red and processed meat intake and risk of colorectal adenomas: a systematic review and meta-analysis of epidemiological studies. Cancer Causes Control (CCC). 2013;24:611–627.

    Article  Google Scholar 

  53. Ye X, Fu J, Yang Y, Chen S. Dose-risk and duration-risk relationships between aspirin and colorectal cancer: a meta-analysis of published cohort studies. PLoS One. 2013;8:e57578.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  54. Ishikawa H, Mutoh M, Suzuki S, et al. The preventive effects of low-dose enteric-coated aspirin tablets on the development of colorectal tumours in Asian patients: a randomised trial. Gut. 2014;63:1755–1759.

  55. Sutcliffe P, Connock M, Gurung T, et al. Aspirin in primary prevention of cardiovascular disease and cancer: a systematic review of the balance of evidence from reviews of randomized trials. PLoS One. 2013;8:e81970.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  56. Rothwell PM, Wilson M, Elwin CE, et al. Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials. Lancet. 2010;376:1741–1750.

    Article  CAS  PubMed  Google Scholar 

  57. Gao F, Liao C, Liu L, Tan A, Cao Y, Mo Z. The effect of aspirin in the recurrence of colorectal adenomas: a meta-analysis of randomized controlled trials. Colorectal Dis Off J Assoc Coloproctol of G B Irel. 2009;11:893–901.

    CAS  Google Scholar 

  58. Durko L, Malecka-Panas E. Lifestyle modifications and colorectal cancer. Curr Colorectal Cancer Rep. 2014;10:45–54.

    Article  PubMed Central  PubMed  Google Scholar 

  59. Howe GR, Benito E, Castelleto R, et al. Dietary intake of fiber and decreased risk of cancers of the colon and rectum: evidence from the combined analysis of 13 case-control studies. J Natl Cancer Inst. 1992;84:1887–1896.

    Article  CAS  PubMed  Google Scholar 

  60. Willett WC, Stampfer MJ, Colditz GA, Rosner BA, Speizer FE. Relation of meat, fat, and fiber intake to the risk of colon cancer in a prospective study among women. N Engl J Med. 1990;323:1664–1672.

    Article  CAS  PubMed  Google Scholar 

  61. Fuchs CS, Giovannucci EL, Colditz GA, et al. Dietary fiber and the risk of colorectal cancer and adenoma in women. N Engl J Med. 1999;340:169–176.

    Article  CAS  PubMed  Google Scholar 

  62. Bingham SA, Day NE, Luben R, et al. Dietary fibre in food and protection against colorectal cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC): an observational study. Lancet. 2003;361:1496–1501.

    Article  PubMed  Google Scholar 

  63. Wolin KY, Yan Y, Colditz GA, Lee IM. Physical activity and colon cancer prevention: a meta-analysis. Br J Cancer. 2009;100:611–616.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  64. Wolin KY, Yan Y, Colditz GA. Physical activity and risk of colon adenoma: a meta-analysis. Br J Cancer. 2011;104:882–885.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  65. Chung M, Lee J, Terasawa T, Lau J. Trikalinos TA. Vitamin D with or without calcium supplementation for prevention of cancer and fractures: an updated meta-analysis for the U.S. Preventive Services Task Force. Ann Intern Med. 2011;155:827–838.

    Article  PubMed  Google Scholar 

  66. Cho E, Smith-Warner SA, Spiegelman D, et al. Dairy foods, calcium, and colorectal cancer: a pooled analysis of 10 cohort studies. J Natl Cancer Inst. 2004;96:1015–1022.

    Article  CAS  PubMed  Google Scholar 

  67. Baron JA, Barry EL, Ahnen DJ, et al. A clinical trial of supplementation with vitamin D and/or calcium for the prevention of colorectal adenomas. San Diego: American Association for Cancer Research; 2014.

    Google Scholar 

  68. Kim DH, Smith-Warner SA, Spiegelman D, et al. Pooled analyses of 13 prospective cohort studies on folate intake and colon cancer. Cancer Causes Control (CCC). 2010;21:1919–1930.

    Article  Google Scholar 

  69. Figueiredo JC, Mott LA, Giovannucci E, et al. Folic acid and prevention of colorectal adenomas: a combined analysis of randomized clinical trials. Int J Cancer (Journal International du Cancer). 2011;129:192–203.

    Article  CAS  Google Scholar 

  70. Anderson JC, Pleau DC, Rajan TV, et al. Increased frequency of serrated aberrant crypt foci among smokers. Am J Gastroenterol. 2010;105:1648–1654.

    Article  PubMed  Google Scholar 

  71. Rustagi T, Anderson JC. Endoscopy-related factors contributing to postcolonoscopy colorectal cancers. Gastroenterology. 2014;146:311–313; discussion 313.

  72. Burnett-Hartman AN, Passarelli MN, Adams SV, et al. Differences in epidemiologic risk factors for colorectal adenomas and serrated polyps by lesion severity and anatomical site. Am J Epidemiol. 2013;177:625–637.

    Article  PubMed Central  PubMed  Google Scholar 

  73. Colditz GA, Atwood KA, Emmons K, et al. Harvard report on cancer prevention volume 4: Harvard cancer risk index. Risk index working group, Harvard Center for Cancer Prevention. Cancer Causes Control (CCC). 2000;11:477–488.

    Article  CAS  Google Scholar 

  74. Freedman AN, Slattery ML, Ballard-Barbash R, et al. Colorectal cancer risk prediction tool for white men and women without known susceptibility. J Clin Oncol Off J Am Soc Clin Oncol. 2009;27:686–693.

    Article  Google Scholar 

  75. Imperiale TF, Wagner DR, Lin CY, Larkin GN, Rogge JD, Ransohoff DF. Using risk for advanced proximal colonic neoplasia to tailor endoscopic screening for colorectal cancer. Ann Intern Med. 2003;139:959–965.

    Article  PubMed  Google Scholar 

  76. Kaminski MF, Polkowski M, Kraszewska E, Rupinski M, Butruk E, Regula J. A score to estimate the likelihood of detecting advanced colorectal neoplasia at colonoscopy. Gut. 2014;63:1112–1119.

    Article  PubMed Central  PubMed  Google Scholar 

  77. Kim DJ, Rockhill B, Colditz GA. Validation of the Harvard Cancer Risk Index: a prediction tool for individual cancer risk. J Clin Epidemiol. 2004;57:332–340.

    Article  PubMed  Google Scholar 

  78. Levitzky BE, Brown CC, Heeren TC, Schroy PC 3rd. Performance of a risk index for advanced proximal colorectal neoplasia among a racially/ethnically diverse patient population (risk index for advanced proximal neoplasia). Am J Gastroenterol. 2011;106:1099–1106.

    Article  PubMed  Google Scholar 

  79. Ma E, Sasazuki S, Iwasaki M, et al. 10-Year risk of colorectal cancer: development and validation of a prediction model in middle-aged Japanese men. Cancer Epidemiol. 2010;34:534–541.

    Article  PubMed  Google Scholar 

  80. Park Y, Freedman AN, Gail MH, et al. Validation of a colorectal cancer risk prediction model among white patients age 50 years and older. J Clin Oncol Off J Am Soc Clin Oncol. 2009;27:694–698.

    Article  Google Scholar 

  81. Schroy PC 3rd, Coe AM, Mylvaganam SR, et al. The Your Disease Risk Index for colorectal cancer is an inaccurate risk stratification tool for advanced colorectal neoplasia at screening colonoscopy. Cancer Prev Res. 2012;5:1044–1052.

    Article  Google Scholar 

  82. Tao S, Hoffmeister M, Brenner H. Development and validation of a scoring system to identify individuals at high risk for advanced colorectal neoplasms who should undergo colonoscopy screening. Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc. 2014;12:478–485.

    Google Scholar 

  83. Wells BJ, Kattan MW, Cooper GS, Jackson L, Koroukian S. Colorectal cancer predicted risk online (CRC-PRO) calculator using data from the multi-ethnic cohort study. J Am Board Fam Med (JABFM). 2014;27:42–55.

    Article  Google Scholar 

  84. Betes M, Munoz-Navas MA, Duque JM, et al. Use of colonoscopy as a primary screening test for colorectal cancer in average risk people. Am J Gastroenterol. 2003;98:2648–2654.

    PubMed  Google Scholar 

  85. Driver JA, Gaziano JM, Gelber RP, Lee IM, Buring JE, Kurth T. Development of a risk score for colorectal cancer in men. Am J Med. 2007;120:257–263.

    Article  PubMed  Google Scholar 

  86. Kastrinos F, Allen JI, Stockwell DH, et al. Development and validation of a colon cancer risk assessment tool for patients undergoing colonoscopy. Am J Gastroenterol. 2009;104:1508–1518.

    Article  PubMed Central  PubMed  Google Scholar 

  87. Lin OS, Kozarek RA, Schembre DB, et al. Risk stratification for colon neoplasia: screening strategies using colonoscopy and computerized tomographic colonography. Gastroenterology. 2006;131:1011–1019.

    Article  PubMed  Google Scholar 

  88. Wong MC, Lam TY, Tsoi KK, et al. A validated tool to predict colorectal neoplasia and inform screening choice for asymptomatic subjects. Gut. 2014;63:1130–1136.

    Article  PubMed  Google Scholar 

  89. Cai QC, Yu ED, Xiao Y, et al. Derivation and validation of a prediction rule for estimating advanced colorectal neoplasm risk in average-risk Chinese. Am J Epidemiol. 2012;175:584–593.

    Article  PubMed  Google Scholar 

  90. Ma GK, Ladabaum U. Personalizing colorectal cancer screening: a systematic review of models to predict risk of colorectal neoplasia. Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc. 2014;12:1624.e1–1634.e1.

  91. Win AK, Macinnis RJ, Hopper JL, Jenkins MA. Risk prediction models for colorectal cancer: a review. Cancer Epidemiol Biomarkers Prev Publ Am Assoc Cancer Res (cosponsored by the American Society of Preventive Oncology). 2012;21:398–410.

    Article  Google Scholar 

  92. Moons KG, Royston P, Vergouwe Y, Grobbee DE, Altman DG. Prognosis and prognostic research: what, why, and how? BMJ. 2009;338:b375.

    Article  PubMed  Google Scholar 

  93. Wasson JH, Sox HC, Neff RK, Goldman L. Clinical prediction rules. Applications and methodological standards. N Engl J Med. 1985;313:793–799.

    Article  CAS  PubMed  Google Scholar 

  94. Bouwmeester W, Zuithoff NP, Mallett S, et al. Reporting and methods in clinical prediction research: a systematic review. PLoS Med. 2012;9:1–12.

    Article  PubMed  Google Scholar 

  95. Bouwens MW, Winkens B, Rondagh EJ, et al. Simple clinical risk score identifies patients with serrated polyps in routine practice. Cancer Prev Res. 2013;6:855–863.

    Article  Google Scholar 

  96. Fisher JA, Fikry C, Troxel AB. Cutting cost and increasing access to colorectal cancer screening: another approach to following the guidelines. Cancer Epidemiol Biomarkers Prev Publ Am Assoc Cancer Res (cosponsored by the American Society of Preventive Oncology). 2006;15:108–113.

    Article  Google Scholar 

  97. Retrieved from http://www.cancer.gov/colorectalcancerrisk/.

  98. Felsen CB, Piasecki A, Ferrante JM, Ohman-Strickland PA, Crabtree BF. Colorectal cancer screening among primary care patients: does risk affect screening behavior? J Community Health. 2011;36:605–611.

    Article  PubMed Central  PubMed  Google Scholar 

  99. Robertson DJ. Prediction models for advanced neoplasia: risky business. Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc. 2013;11:703–704.

    Google Scholar 

  100. Moser RP, McCaul K, Peters E, Nelson W, Marcus SE. Associations of perceived risk and worry with cancer health-protective actions: data from the Health Information National Trends Survey (HINTS). J Health Psychol. 2007;12:53–65.

    Article  PubMed  Google Scholar 

  101. Wang JH, Liang W, Chen MY, et al. The influence of culture and cancer worry on colon cancer screening among older Chinese-American women. Ethn Dis. 2006;16:404–411.

    PubMed Central  PubMed  Google Scholar 

  102. Llanos AA, Pennell ML, Young GS, Tatum CM, Katz ML, Paskett ED. No association between colorectal cancer worry and screening uptake in Appalachian Ohio. J Public Health. 2014. doi:10.1093/pubmed/fdu031.

  103. Lowery JT, Horick N, Kinney AY, et al. A randomized trial to increase colonoscopy screening in members of high-risk families in the colorectal cancer family registry and cancer genetics network. Cancer Epidemiol Biomarkers Prev Publ Am Assoc Cancer Res (cosponsored by the American Society of Preventive Oncology). 2014;23:601–610.

    Article  Google Scholar 

  104. Parkin DM, Olsen AH, Sasieni P. The potential for prevention of colorectal cancer in the UK. Eur J Cancer Prev. 2009;18:179–190.

    Article  PubMed  Google Scholar 

  105. Anderson AS, Craigie AM, Caswell S, et al. The impact of a bodyweight and physical activity intervention (BeWEL) initiated through a national colorectal cancer screening programme: randomised controlled trial. BMJ. 2014;348:g1823.

    Article  PubMed Central  PubMed  Google Scholar 

  106. Moshkowitz M, Shapira S, Arber N. Chemoprevention for advanced CR neoplasia. Best Pract Res Clin Gastroenterol. 2011;25:623–630.

    Article  CAS  PubMed  Google Scholar 

  107. Kim DH, Cha JM, Shin HP, Joo KR, Lee JI, Park DI. Development and validation of a risk stratification-based screening model for predicting colorectal advanced neoplasia in Korea. J Clin Gastroenterol. 2015;49:41–49.

  108. Fan J, Upadhye S, Worster A. Understanding receiver operating characteristic (ROC) curves. CJEM. 2006;8:19–20.

    PubMed  Google Scholar 

  109. Wei EK, Colditz GA, Giovannucci EL, Fuchs CS, Rosner BA. Cumulative risk of colon cancer up to age 70 years by risk factor status using data from the Nurses’ Health Study. Am J Epidemiol. 2009;170:863–872.

    Article  PubMed Central  PubMed  Google Scholar 

  110. Yeoh KG, Ho KY, Chiu HM, et al. The Asia-Pacific Colorectal Screening score: a validated tool that stratifies risk for colorectal advanced neoplasia in asymptomatic Asian subjects. Gut. 2011;60:1236–1241.

    Article  PubMed  Google Scholar 

  111. Kaminski MF, Regula J, Kraszewska E, et al. Quality indicators for colonoscopy and the risk of interval cancer. N Engl J Med. 2010;362:1795–1803.

    Article  CAS  PubMed  Google Scholar 

  112. Rehm J, Irving H, Ye Y, Kerr WC, Bond J, Greenfield TK. Are lifetime abstainers the best control group in alcohol epidemiology? On the stability and validity of reported lifetime abstention. Am J Epidemiol. 2008;168:866–871.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  113. Buc E, Kwiatkowski F, Alves A, Panis Y, Mantion G, Slim K. Tobacco smoking: a factor of early onset of colorectal cancer. Dis Colon Rectum. 2006;49:1893–1896.

    Article  PubMed  Google Scholar 

  114. Zisman AL, Nickolov A, Brand RE, Gorchow A, Roy HK. Associations between the age at diagnosis and location of colorectal cancer and the use of alcohol and tobacco: implications for screening. Arch Intern Med. 2006;166:629–634.

    Article  PubMed  Google Scholar 

  115. Michalek AM, Cummings KM. The association between cigarette smoking and age at cancer diagnosis. Hum Biol. 1987;59:631–639.

    CAS  PubMed  Google Scholar 

  116. Peppone LJ, Mahoney MC, Cummings KM, et al. Colorectal cancer occurs earlier in those exposed to tobacco smoke: implications for screening. J Cancer Res Clin Oncol. 2008;134:743–751.

    Article  PubMed Central  PubMed  Google Scholar 

  117. Chang LC, Wu MS, Tu CH, Lee YC, Shun CT, Chiu HM. Metabolic syndrome and smoking may justify earlier colorectal cancer screening in men. Gastrointest Endosc. 2014;79:961–969.

    Article  PubMed  Google Scholar 

  118. Chung SJ, Kim YS, Yang SY, et al. Prevalence and risk of colorectal adenoma in asymptomatic Koreans aged 40–49 years undergoing screening colonoscopy. J Gastroenterol Hepatol. 2010;25:519–525.

    Article  PubMed  Google Scholar 

  119. Messina CR, Lane DS, Anderson JC. Perceptions of risk factors for colorectal cancer and colorectal cancer risk-related behaviors among current, ex-, and nonsmokers. J Cancer Educ Off J Am Assoc Cancer Educ. 2013;28:444–453.

    Article  Google Scholar 

  120. Oluyemi AO, Welch AR, Yoo LJ, Lehman EB, McGarrity TJ, Chuang CH. Colorectal cancer screening in high-risk groups is increasing, although current smokers fall behind. Cancer. 2014;120:2106–2113.

  121. Messina CR, Lane DS, Anderson JC. Body mass index and screening for colorectal cancer: gender and attitudinal factors. Cancer Epidemiol. 2012;36:400–408.

    Article  PubMed Central  PubMed  Google Scholar 

  122. Maruthur NM, Bolen S, Gudzune K, Brancati FL, Clark JM. Body mass index and colon cancer screening: a systematic review and meta-analysis. Cancer Epidemiol Biomarkers Prev Publ Am Assoc Cancer Res (cosponsored by the American Society of Preventive Oncology). 2012;21:737–746.

    Article  Google Scholar 

  123. Anderson JC, Fortinsky RH, Kleppinger A, Merz-Beyus AB, Huntington CG 3rd, Lagarde S. Predictors of compliance with free endoscopic colorectal cancer screening in uninsured adults. J Gen Intern Med. 2011;26:875–880.

    Article  PubMed Central  PubMed  Google Scholar 

  124. Borg BB, Gupta NK, Zuckerman GR, Banerjee B, Gyawali CP. Impact of obesity on bowel preparation for colonoscopy. Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc. 2009;7:670–675.

    Google Scholar 

  125. de Vries E, Soerjomataram I, Lemmens VE, et al. Lifestyle changes and reduction of colon cancer incidence in Europe: a scenario study of physical activity promotion and weight reduction. Eur J Cancer. 2010;46:2605–2616.

    Article  PubMed  Google Scholar 

  126. Yamaji Y, Okamoto M, Yoshida H, et al. The effect of body weight reduction on the incidence of colorectal adenoma. Am J Gastroenterol. 2008;103:2061–2067.

    Article  PubMed  Google Scholar 

  127. Laiyemo AO, Doubeni C, Badurdeen DS, et al. Obesity, weight change, and risk of adenoma recurrence: a prospective trial. Endoscopy. 2012;44:813–818.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  128. Schroy PC 3rd, Coe A, Chen CA, O’Brien MJ, Heeren TC. Prevalence of advanced colorectal neoplasia in white and black patients undergoing screening colonoscopy in a safety-net hospital. Ann Intern Med. 2013;159:13–20.

    Article  PubMed Central  PubMed  Google Scholar 

  129. Anderson JC. Prevalence of advanced neoplasia in black versus white patients. Gastroenterology. 2014;146:856–858.

    Article  PubMed  Google Scholar 

  130. Schmalfuss F, Kolominsky-Rabas PL. Personalized medicine in screening for malignant disease: a review of methods and applications. Biomarker Insights. 2013;8:9–14.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  131. Raimondi S, Botteri E, Iodice S, Lowenfels AB, Maisonneuve P. Gene-smoking interaction on colorectal adenoma and cancer risk: review and meta-analysis. Mutat Res. 2009;670:6–14.

    Article  CAS  PubMed  Google Scholar 

  132. Ding W, Zhou DL, Jiang X, Lu LS. Methionine synthase A2756G polymorphism and risk of colorectal adenoma and cancer: evidence based on 27 studies. PLoS One. 2013;8:e60508.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  133. Anderson JC, Swede H, Rustagi T, et al. Aberrant crypt foci as predictors of colorectal neoplasia on repeat colonoscopy. Cancer Causes Control (CCC). 2012;23:355–361.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Veterans Affairs Medical Center, White River Junction, VT, USA

    Joseph C. Anderson

  2. The Geisel School of Medicine at Dartmouth, Hanover, NH, USA

    Joseph C. Anderson

  3. Division of Gastroenterology and Hepatology, University of Connecticut School of Medicine, Farmington, CT, 06030, USA

    Ethan Bortniker

Authors
  1. Ethan Bortniker
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Joseph C. Anderson
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Joseph C. Anderson.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bortniker, E., Anderson, J.C. Do Recent Epidemiologic Observations Impact Who and How We Should Screen for CRC?. Dig Dis Sci 60, 781–794 (2015). https://doi.org/10.1007/s10620-014-3467-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10620-014-3467-x

Keywords

Search

Navigation